THE UNCERTAIN PROMISE OF A COVID-19 VACCINE: WHAT WE’RE NOT BEING TOLD

With the prospects of a second wave of infection later in the years, many are holding out for the promise of a COVID-19 vaccine. The promise being offered by the World Health Organization, governments, vaccine developers and funders like the Bill and Melinda Gates Foundation is that a vaccine will eliminate the danger of the virus and release us from lockdowns, social distancing and other measures that have created the biggest disruption to human life and economies seen for over 70 years. But the process of developing safe and vaccines using technologies that have never been used on a large scale, and doing this under an unprecedented warp speed time-frame, is far from straightforward.

____________________________________________________________________________________________________

Bill Gates Confronted About Widespread Vaccine Side Effects

Bill Gates Confronted About Widespread Vaccine Side Effects

At least 80% of trial subjects reportedly suffering side effects

BY PATRICK HOWLEY-NATIONAL FILE

SEE: https://www.infowars.com/bill-gates-confronted-about-widespread-vaccine-side-effects/;

republished below in full unedited for informational, educational & research purposes:

Vaccine oligarch Bill Gates expressed apathy in a CBS interview about the fact that his Moderna Coronavirus vaccine, which National Institutes of Health (NIH) has a financial stake in, is testing horribly in vaccine trials, with at least 80 percent of trial subjects reportedly suffering side effects.

This news comes on the heels of a major protest in Africa against the vaccine being tested on black people on the continent. Military insurer Tricare admitted that it wrongly told more than 600,000 U.S. military members that they had the virus.

Hospitals in Florida are showing massive problems with testing accuracy, with Orlando Health admitting that its 98 percent positive rate was actually 9.4 percent.

The CDC admitted that it is mixing antibody and viral test results to derive its case numbers and you can test positive on an antibody test if you have antibodies from a family of viruses that cause the common cold. Here is Gates responding to vaccine side effects:

No wonder people in Africa are protesting the vaccine tests.

National Institutes of Health (NIH) own a financial stake in the Bill Gates-funded Moderna Coronavirus vaccine, raising big questions about the supposed impartiality of the federal government’s policy decisions during the Coronavirus outbreak. NIAID director Dr. Anthony Fauci, a financial ally of Bill Gates whose institute is part of NIH, has been critical of Hydroxychloroquine and the FBI even raided a health spa serving intravenous vitamin C, which are competitors to a vaccine.

“We do have some particular stake in the intellectual property” for the Moderna vaccine stated Francis Collins, the director of NIH, in a revelatory recent Economic Club panel discussion. “One of the vaccines– the one that’s furthest along– what started, actually, at the federal government in our own Vaccine Research Center at NIH– then worked with a biotechnology company called Moderna to get to where we are now, with very impressive Phase I results and getting ready to go into a large-scale trial as early as July. That one, of course, we do have some particular stake in the intellectual property. Others, though, come from companies who’ve invested their efforts into getting them to the point where they might now be ready for a trial,” Collins stated.

Newly published documents from Public Citizen have massive implications. Public Citizen states:

“The U.S. government may jointly own a potential coronavirus vaccine. The National Institutes of Health (NIH) has played a critical role in coronavirus research for years. Building off this work, federal scientists have helped design and test mRNA-1273—a vaccine candidate developed in partnership with Moderna.[2] The federal government has filed multiple patents covering mRNA-1273. In this report, we describe two patent applications that list federal scientists as co-inventors.[3] If the government successfully pursued its patent filings, the resulting patents would likely confer significant rights. We also review recently disclosed contracts between NIH and Moderna. The agreements suggest that NIH has not transferred its rights, but instead maintains a joint stake.”

Eight members of the National Institutes of Health (NIH) expert COVID-19 Treatment Guidelines Panel disclosed recent financial relationships with Gilead, the drugmaker that is introducing an expensive Coronavirus competitor to Hydroxychloroquine, the inexpensive anti-malarial drug that President Trump has promoted which many people claim has helped them. This financial relationship between NIH experts and Gilead is especially concerning in light of revelations that NIH has a financial stake in the Bill Gates-funded Moderna vaccine, another competitor to Hydroxychloroquine. Chloroquine critic Dr. Anthony Fauci’s NIAID, which funded the Bat Coronavirus research at the Wuhan Institute of Virology believed to be the source of the outbreak, is part of NIH.

HERE IS THE FINANCIAL DISCLOSURE LIST FOR THE NIH EXPERT CORONAVIRUS TREATMENT PANEL. The experts with disclosed ties to Gilead include consultants, people who provided Gilead research support, and honoraria. Members of the panel also disclosed ties to Merck and INOVIO Pharmaceuticals, which took $9 million from a Gates-backed company to develop a Coronavirus vaccine.

Gilead is driving up their prices from what was previously expected (as the company has done in the past, sparking bipartisan condemnation from Senators Grassley and Wyden). No wonder, then, VA study.

President Donald Trump is now officially vindicated with facts on his support for the anti-malarial drug Hydroxychloroquine.

“What we’re finding clinically with our patients is that it really only works in conjunction with Zinc,” stated Los Angeles emergency room specialist Dr. Anthony Cardillo. “So the hydroxychloroquine opens a zinc channel, zinc goes into the cell, it then blocks the replication of the cellular machinery….Every patient I’ve prescribed it to has been very very ill and within 8 to 12 hours they were basically symptom free.”

Bill Gates Is Already Looking Forward to The ‘Next’ Pandemic

Fauci Does Not Bother To Wear A Mask In Public, As Evidenced By His Pitiful First-Pitch Showing At Baseball’s Opening Day.

Fauci Also Took Off His Mask After He Testified In A Washington Hearing

Why did the Bill and Melinda Gates Foundation fund research at MIT on how to implant people’s vaccination history under their skin? Why did Fauci meet with Bill Gates’ father, George Soros, and other globalist heavyweights all the way back in 2001? Why did the Stephen King-created television series The Dead Zone predict the Coronavirus outbreak — and a Chloroquine cure for it — back in 2003?

Why did Dr. Anthony Fauci’s NIAID fund the Coronavirus bat research at the Wuhan Institute of Virology, which President Trump and Secretary of State Pompeo and others have identified as the source of the worldwide outbreak?

HERE’S THE REAL STORY OF CONTACT TRACING


Alex Jones breaks down why people are receiving a positive COVID-19 diagnosis without being tested.

______________________________________________________________________________________________

A Grade 3 Vaccine-Related Adverse Event is Serious 

BY MARCO CACERES

SEE: https://thevaccinereaction.org/2020/07/a-grade-3-vaccine-related-adverse-event-is-serious/;

republished below in full unedited for informational, educational & research purposes:

When Moderna, Inc. announced on May 18, 2020 the results of a Phase I human clinical trial for its experimental mRNA-1273 vaccine for COVID-19, the biotechnology company said the vaccine had produced no “serious adverse events” (SAEs) among the 45 people who participated in the trial and that it considered the vaccine to be “generally safe” and “well-tolerated.” Moderna acknowledged that four (nine percent) of the trial participants suffered Grade 3 adverse events to its vaccine.1 2 3 4 5

In its report (published in The Lancet on May 22) on the results of a Phase I human clinical trial for its experimental Ad5-nCoV for COVID-19, CanSino Biologics, Inc. said it had noted no “serious adverse event” among the 108 trial participants. The Chinese biotech company, working in partnership with China’s Academy of Military Medical Sciences’ Institute of Biotechnology, acknowledged that 10 (nine percent) of the participants suffered Grade 3 adverse events to its vaccine.6 7 8

On July 20, Pfizer, Inc. and Germany’s BioNTech SE announced the results of their Phase I/II human clinical trial for their jointly-developed experimental BNT162b1 vaccine for COVID-19. The companies reported “no serious adverse events” among its 45 trial participants, although they did acknowledge that two (four percent) of the participants suffered Grade 3 adverse events to their vaccine.9 10 11 12

Almost 1 in 10 COVID-19 Trial Participants Suffered Serious Reactions

A total of 198 healthy people participated in the Moderna, CanSino Biologics and Pfizer/BioNTech Phase I and Phase I/II clinical trials. The companies said no serious adverse events were experienced during the trials, and yet they acknowledged a total of 16 Grade 3 adverse events? How is that possible, given that a Grade 3 adverse event is defined by the U.S. Department of Health and Human Services (HHS) as, “severe or medically significant but not immediately life-threatening; hospitalization or prolongation of hospitalization indicated; disabling; limiting self care” such as “bathing, dressing and undressing, feeding self, using the toilet, taking medications”?13

In other words, a Grade 3 adverse event is serious. It is only one grade removed from “life-threatening” (Grade 4) and just two grades from “death” (Grade 5).13 Of the 198 participants in the Moderna, CanSino Biologics and Pfizer/BioNTech clinical trials, 16 (eight percent) of them suffered serious adverse events. Imagine if those vaccines had been given to 100 million people, which could have resulted in some 8 million serious adverse events and many questions about potential long-term adverse health outcomes

Of the 198 participants in the Moderna, CanSino Biologics and Pfizer/BioNTech clinical trials, 16 (eight percent) of them suffered serious adverse events. Imagine if those vaccines had been given to 100 million people.

AstraZeneca and University of Oxford Report Zero Serious Adverse Events in Clinical Trial for Their COVID-19 Vaccine

Most recently, the University of Oxford and British-Swiss pharmaceutical firm AstraZeneca plc reported the results of a Phase I/II human clinical trial for their experimental AZD1222 vaccine (formerly known as ChAdOx1 nCoV-19) for COVID-19. According to the results, published in The Lancet on July 20, there were no “serious adverse events” related to the vaccine among the 1,077 trial participants.14 15

CNN headline about the Oxford/AstraZeneca clinical trial results read, “Oxford’s COVID-19 vaccine appears safe and induces immune response, early results suggest, but more research is needed.”

It appears safe?

References:

1 Moderna’s COVID-19 Vaccine Speeds to Phase III Trial After More Positive DataClinical OMICS July 15, 2020.
2 Business Wire. Moderna Announces Publication in The New England Journal of Medicine of Interim Results From Phase 1 Study of Its mRNA Vaccine Against COVID-19 (mRNA-1273). Moderna July 14, 2020.
3 Cáceres M. Healthy Clinical Trial Subjects Suffer Grade 3 Side Effects to Moderna’s mRNA COVID-19 VaccineThe Vaccine Reaction May 24, 2020.
4 Cáceres M. Volunteer Describes His Serious Reaction in Moderna’s mRNA COVID-19 Vaccine TrialThe Vaccine Reaction May 30, 2020.
5 Press Release. Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus. Moderna May 18, 2020.
6 Branswell H. Early study of Covid-19 vaccine developed in China sees mixed resultsSTAT May 22, 2020.
7 Cáceres M, Fisher BL. 81 Percent of Clinical Trial Volunteers Suffer Reactions to CanSino Biologics’ COVID-19 Vaccine That Uses HEK293 Human Fetal Cell LinesThe Vaccine Reaction July 6, 2020.
8 Hou LH, et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trialThe Lancet June 13, 2020; 395 (10240): 1845-1854.
9 Herper M. Covid-19 vaccine from Pfizer and BioNTech shows positive resultsSTAT July 1, 2020.
10 Mulligan MJ, et al. Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim ReportmedRxXiv July 1, 2020.
11 Press Release. Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data. Pfizer July 20, 2020.
12 TVR Staff. Pfizer/BioNTech’s COVID-19 Vaccine Causes Adverse Reactions in Over Half of Clinical Trial VolunteersThe Vaccine Reaction July 18, 2020.
13 U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Nov. 27, 2017.
14 Gumbrecht J, Thomas N, Vigue D, Howard J. Oxford’s Covid-19 vaccine appears safe and induces immune response, early results suggest, but more research is neededCNN July 21, 2020.
15 Folegatti PM, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialThe Lancet July 20, 2020.